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Seven patients were evaluated at a mean duration of 8.4 yr after sustaining inhalational injury associated with 
burns. At the time of re-examination, the patients were asymptomatic and had normal chest X-rays, and 
arterial blood gases. Three of the seven patients had abnormally elevated serum calcitonin levels. The 
spirometry (FEV,) measurements showed an inverse trend to that of the serum calcitonin levels. The elevated 
calcitonin levels had an abnormal predominance of the procalcitonin component as assessed by several region 
specific antisera. The serum calcitonin also showed a significant correlation with the hormone level which had 
been obtained at the time of prior discharge from the hospital (r=0.91). 
Although there appears to be no or minimal chronic pulmonary sequela to inhalational injury in burns by 
pulmonary testing, we speculate that the hyperprocalcitonemia in some of the patients may reflect a long-term 
hyperplastic response of the bronchio-epithelial pulmonary neuroendocrine cells. The potential significance of 
this and other lung-associated endocrine markers is discussed. 
Although fire victims and fire fighters have been 
reported to sustain both acute and chronic changes in 
pulmonary function testing (l), there is a paucity of 
information regarding the metabolicendocrine 
response of the lung associated with smoke inhala- 
tion. The serum angiotensin-l-converting enzyme 
activity (ACE) has been reported to be altered in 
experimental and clinical studies of lung injury 
including smoke inhalation (2). In our own studies, 
we noted hypercalcitonemia in acutely burned 
patients which was associated with inhalational 
exposure and which was correlated with mortality 
(3). This hypercalcitonemia was characterized by 
increased circulating levels of procalcitonin (4) 
suggesting that the elevated levels emanate from the 
pulmonary neuroendocrine cell (5). 
To evaluate further the use of serum calcitonin 
(CT) as an endocrine marker of pulmonary damage, 
we re-examined the pulmonary status and the 
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serum CT levels in previously burned patients with 
inhalational injury using several antisera including 
a newly developed assay for the l-57 amino acid 
N-terminal flanking peptide portion of human 
procalcitonin (6). 
Methods 
The 28 survivors of our previous study (3) were 
identified and an attempt made to contact them for a 
follow-up study approved by the Ethics Committee 
at the Washington Hospital Center. A total of seven 
patients (22% of total) responded and were enrolled. 
All seven patients met the criteria of normal renal 
function and cessation of all cigarette smoking 24 h 
prior to the study. The following studies were per- 
formed: history and physical examination (concen- 
trating on the pulmonary system); an arterial blood 
gas at room air; chest X-ray (PA and lateral views); 
pulmonary function testing (FEV,); and a fasting 
serum CT. The serum was frozen at - 70°C until 
radioimmunoassay (RIA). The antiserum AbIIIb is 
recognizant of the mid-portion of CT and the AbIV 
antiserum is directed towards the C-terminal region. 
AbIIIb serum CT levels reflect the presence of high 
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Fig. I G-75 Sephadex gel chromatography of sera from a burn patient using the nProCT and the AbIIIb CT 
radioimmunoassays. A denotes the elution position of the intact procalcitonin and B the position of the 1-57 nProCT 
fragment. Note the paucity of immunoreactivity eluting with the Kav of the CT-monomer (0.65). 0, nProCT; 0, hCT. 
molecular weight species of calcitonin while AbIV 
serum CT levels largely reflect CT monomer. 
We have recently also developed a rabbit anti- 
serum to the 1-57 amino acid N-terminal portion of 
proCT (nProCT). This antiserum recognizes, in addi- 
tion to proCT, proCT fragments and proCGRP (6). 
The RIA is performed using a rabbit anti-human 
antibody (R2B6) at a dilution of 1:60 000 in a 0.2% 
gelatin buffer (0.13 M H3B03 containing 9 g NaCl, 
2 g gelatin, 1 ml Triton x 100 and 0.1 g merthio- 
late 1 - ’ at a pH of 7.5). The R2B6 is pre-incubated 
with standards (Bachem) or unknown (l&50$) in 
0.2 ml at 4°C for 3 days. 1251-nProCT and 50,ul goat 
anti-rabbit IgG bound to iron particles are added and 
incubated in a volume of 0.5 ml at 4°C for 2 days. 
Bound and free hormones are separated with mag- 
netic tube racks. Sensitivity = 2 pg; 50% BIB, = 20 pg; 
maximum bound=30%. The R2B6 antiserum cross- 
reacts with both pro-hCT and pro-hCGRP as seen 
with HPLC (6). There is no cross-reactivity with 
either CT or CGRP. Fig. 1 shows the elution position 
of proCT and fragments using G-75 Sephadex filtra- 
tion gel chromatography. In order to compare the 
various CT antisera, we reassayed 134 sera from 
acute burn victims in our previous study (3). 
Results 
The clinical and pulmonary data obtained are 
summarized in Table 1. By history, all patients had 
sustained inhalational exposure. All patients reported 
that they were in good health, and none had been 
hospitalized or treated as outpatients since discharge 
from the bum accident. There was no current impedi- 
ment related to pulmonary function, except for one 
patient (DF) who complained of mild wheezing fol- 
lowing exercise during the years subsequent to the 
bum. The physical examination was entirely normal 
in all patients. The mean carboxyhaemoglobin levels 
in the smokers (n=4) was 7.6 and in the non-smokers 
(n=3) was 4.1. 
The mean serum CT for AbIIIb at this follow- 
up was 259 5 155 pgml- ’ (normal less than 
200 pg ml ~ ‘); and for AbIV, 67 & 48 pg ml - ’ (nor- 
mal less than 100 pg ml - ‘). Figure 2 shows the 
relationship between the CT levels (AbIIIb) of this 
follow-up study compared to the levels obtained 
during the first 6 h of admission (a), at the peak level 
of CT during that admission (b), and at the time of 
discharge (c). Only one patient (DF) did not have an 
elevated serum CT at any time during the treatment; 
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Table I Clinical data of seven patients with prior bum and inhalational injury 
Exposure Chest ‘%I FEV,/ Smoker CT3* CT4* nProCT 
Subject Sex (yr) X-ray pH PO, Pco, pred. (ppd) Sx (pgml-‘1 (pgmlm’) (porn-‘) 
MC M 10 NACCPD 7.40 94 40 86 0 0 113 
TD M 7 NACCPD 7.41 81 39 62 1.5 0 742 
RW M 8 NACCPD 7.43 91 37 89 <l 0 368 
SK M 8 NACCPD 7.38 91 42 70 0 0 96 
SG M 10 NACCPD 7.40 72 39 109 1 0 62 
PM F 8 NACCPD 7.42 91 37 70 1.5 0 362 
DF F 8 NACCPD 7.40 94 41 109 0 Y 67 
Mean 8.4 7.41 88 39 85 259 
SD 1.0 0.01 7.6 1.7 18 233 
37 74 
99 182 
183 109 
37 39 
37 61 
37 174 
43 97 
67 105 
52 51 
NACCPD, No active or chronic cardio-pulmonary disease; CT3, AbIIIb calcitonin antibody (normals and smokers 
~200 pg ml - ‘); CT4, AbIV calcitonin antibody (normals and smokers < 100 pg ml - ‘); nProCT, procalcitonin antibody 
(normal c 100 pg ml - ‘); Sx, symptoms; Y, exertional wheezing; ppd, pack per day of smoking; *, using Peninsula hCT 
standards, the CT3 Ab levels are 50% lower and CT4 levels are 20”/;1 lower. 
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Fig. 2 The serum calcitonin level (AbIIIb) in seven patients with burns and inhalational exposure. (a) shows the correlation 
of the initial calcitonin level obtained at admission to the hospital with the calcitonin level 8.4 yr later. (b) and (c) show the 
correlation of the follow-up level of calcitonin with the peak calcitonin obtained during the hospitalization (b) and the level 
of calcitonin obtained at discharge (c). The cross-hatched boxes show the range of normal for this assay. 
she had a burn of the upper trunk associated with 
inhalation of vinyl fumes following a car fire. One 
patient (SK) was a fire fighter who was wearing a 
mask during the fire and smoke exposure. As seen in 
Fig. 2(c), there is a significant correlation of the 
serum CT at the time of discharge and the follow-up 
level (F0.909). 
As a measure of prohormone level, the mean ratio 
of AbIIIb to AbIV in all seven patients was 
3.23 ZL 0.78 (the normal ratio is 144 f 044). The 
ratio in the patients who had an elevated AbIIIb was 
4.63 rt 0.95. 
In 134 sera of patients with bum injury, there was 
a significant correlation between the serum level of 
AbIIIb and nProCT (r=0.91) (Fig. 3) and AbIV and 
nProCT (rz0.86) (Fig. 4). As can be appreciated 
from these two figures, AbIIIb is more sensitive to 
the proCT component compared to AbIV. Further- 
more, nProCT was elevated in the three patients with 
high levels of AbIIIb at 8.4 yr follow-up, while 
those four patients with normal AbIIIb levels also 
demonstrated normal levels of nProCT (Table 1). 
Discussion 
In accordance with other studies (l), there did not 
appear to be significant impairment in lung function 
at a mean of 8.4 yr after the burn exposure. Only one 
patient (DF) complained of exercise wheezing follow- 
ing the burn, although the objective parameters were 
normal. There appeared to be an inverse relationship 
between % FEV, and the serum CT level in this 
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Fig. 3 Regression analysis of 134 sera from patients with 
acute burn using AbIIIb (mid-portion recognizing) and 
nProCT antisera (r=0.91) using the log values of molar 
concentrations. The cross-hatched area represents the 
normal range. 
study, although regression analysis failed to reach 
significance (r = 0.675; P= 0.1). However, other stud- 
ies in fire fighters have documented that a proportion 
of such subjects do show a decline in pulmonary 
function following smoke inhalation, including 
FEV,, mean transit time, increased airway reactivity, 
and the development of asthma (1,7-10). In addition, 
fire fighters may be more susceptible to die from 
non-malignant respiratory diseases (11). Other pul- 
monary complications which have been reported in 
burns include bronchiolitis obliterans and tracheal 
stenosis (12) endobronchial polyposis (13), severe 
and irreversible airflow obstruction (14,15), asthma 
(16) and increased pulmonary resistance (17). 
Bronchiectasis was documented in one well studied 
patient 12 yr after the burn (18). It was later reported 
that 8 yr subsequently, this patient required oxygen 
therapy. 
The metabolic abnormality uncovered in this study 
appeared only in those patients that were discharged 
from the hospital with abnormal levels of CT. In 
these patients, the serum CT was still abnormally 
elevated several years later. Interestingly, the % FEV, 
was reduced in the patients with high CT levels 
(Table l), although this was not statistically signifi- 
cant. We have previously reported increased CT in 
patients with clinically overt chronic obstructive 
pulmonary disease (COPD) (19). The possibility that 
the high CT seen in this study might have been 
related to COPD and/or cigarette smoking was mini- 
mized by the voluntary cessation of smoking 24 h 
prior to this study. Furthermore, although we have 
shown that cigarette smoking can acutely (within 2 h) 
raise CT (20) we have been unable to document any 
difference between the levels of serum CT among 
current smokers, prior smokers, or never-smokers 
(21). However, repeated exposure to cigarette 
smoking or hypoxia (in COPD) could conceivably 
have a trophic effect on sensitized pulmonary 
neuroendocrine cells (PNEC) (22). 
1 10 100 
AbIV hCT (fmol ml-‘) 
Fig. 4 Regression analysis for 134 sera of patients with acute burn using AbIV (C-terminal recognizing) and nProCT 
antisera (r=O.86) using the log values of molar concentrations. The cross-hatched area represents the normal range. 
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As in our previous study (4), it appears that 
the high serum CT level is related primarily to the 
procalcitonin component as evidenced both by the 
elevated ratio of AbIIIb to AbIV and the elevated 
level of proCT detected by RIA. The validity of these 
immunological methods has been documented by 
HPLC and gel chromatography (4,6) (Figs 1,3,4). As 
previously discussed, although serum CT may have a 
diverse origin, the proCT is most likely to originate 
from PNEC. Thus, there appears to be a permanent 
change in the secretory phenotype of these cells. In 
our previous studies, normal PNEC, either, in vivo or 
in vitro, secrete predominantly the CT monomer 
(23,24). It is of some interest that a similar procalci- 
tonin predominance is seen in hyperplastic PNEC 
and in PNEC-associated cancer including small cell 
lung cancer and the bronchial carcinoid (25,26). 
Thus, although confirmatory post mortem studies 
should be performed, we would speculate that these 
burned patients have hypercalcitonemia because of 
persistence of hyperplasia of the PNEC. Presumably, 
the correlation of the serum CT at discharge with 
that of the follow-up CT reflects an initiation and a 
sustainment of this hyperplastic PNEC state. It is 
noteworthy that in some experimental conditions, 
this hyperplasia of PNEC appears to be reversible 
(27). The persistence of hyperprocalcitonemia sug- 
gests a profound phenotypic alteration in the 
stimulus-secretion mechanism of the PNEC. 
The incidence of lung cancer may be increased 
following prior exposure to inhalation of combustion 
products of organic materials. In workers at an 
incinerator who were exposed chronically to the 
smoke of burning waste, the mortality from lung 
cancer has been reported to be increased by 3.5fold 
(28). There are currently no data in the literature 
available on the risk of lung cancer from a single 
severe inhalational burn. Also, it is not known 
whether hyperplastic PNE cells are more susceptible 
to transformation, although in experimentally 
induced neuroendocrine lung cancer in hamsters, 
there appears to be a stage of initial hyperplasia 
preceding tumour formation (27). 
It is unknown how often patients with smoke 
inhalation have long-term sequela. Due to the vari- 
able nature of smoke inhalation and the lack of 
objective parameters, it is often not possible to pre- 
dict who is at a higher risk. The lungs constitute a 
very complex metabolic-endocrine system (29), and 
finding a marker for lung damage would be very 
useful. In this context, it has been reported that the 
serum ACE level may have some value. In view of the 
findings in our studies, the serum level of procalci- 
tonin during the first 48 h is prognostic for survival 
(3). Furthermore, as seen in this study, an elevated 
level of procalcitonin at discharge may serve as a 
prospective marker of lung damage. 
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